Contents

Current Pharmaceutical Design, Volume 20 - Number 28

Editorial

Editorial (Thematic Issue: Helicobacter pylori Eradication Therapy: Advantages and Disadvantages)

, 20(28): 4487 - 4488

Justyna Bien, Maria Bozko, Nisar P. Malek and Przemyslaw Bozko


DOI: 10.2174/138161282028140704103024




Strategy for the Treatment of Helicobacter pylori Infection

, 20(28): 4489 - 4500

Seiji Shiota and Yoshio Yamaoka


DOI: 10.2174/13816128113196660731




Population Based Helicobacter pylori Screening and Eradication: Advances Versus Side Effects

, 20(28): 4501 - 4509

Prof Bojan Tepes


DOI: 10.2174/13816128113196660733




Choosing Optimal Firstline Helicobacter pylori Therapy: a View from a Region with High Rates of Antibiotic Resistance

, 20(28): 4510 - 4516

Alexander A. Nijevitch, Bulat Idrisov, Elsa N. Akhmadeeva and David Y. Graham


DOI: 10.2174/13816128113196660728




Is Helicobacter pylori Always a "Bad Guy"?

, 20(28): 4517 - 4520

Iva Hojsak and Sanja Kola cek


DOI: 10.2174/13816128113196660725




Current and Future Insights in H. pylori Eradication Regimens: The Need of Tailoring Therapy

, 20(28): 4521 - 4532

Vasilios Papastergiou, Sotirios D. Georgopoulos and Stylianos Karatapanis


DOI: 10.2174/13816128113196660726




Editorial

Editorial: Gut Microbiota and Gastrointestinal Diseases: To Treat or Not to Treat

, 20(28): 4533 - 4534

Justyna Bien, Maria Bozko, Nisar P. Malek and Przemyslaw Bozko


DOI: 10.2174/13816128113196660732




Impact of Antibiotics on the Intestinal Microbiota and on the Treatment of Shiga-toxin-Producing Escherichia coli and Salmonella Infections

, 20(28): 4535 - 4548

Jolanta Szych, Tomasz Wo lkowicz, Roberto La Ragione and Grzegorz Madajczak


DOI: 10.2174/13816128113196660730




Clostridium difficile Infection in Children with Inflammatory Bowel Disease: Current Evidence

, 20(28): 4549 - 4555

Aleksandra Banaszkiewicz and Hanna Pituch


DOI: 10.2174/13816128113196660729




Probiotics in the Management of Crohn's disease and Ulcerative Colitis

, 20(28): 4556 - 4560

Katalin Mullner, Pal Miheller, Laszlo Herszenyi and Zsolt Tulassay


DOI: 10.2174/13816128113196660727




Role of Probiotics in the Management of Pouchitis

, 20(28): 4561 - 4564

Mario Guslandi


DOI: 10.2174/13816128113196660724




Role of Yeasts in Healthy and Impaired Gut Microbiota: The Gut Mycome

, 20(28): 4565 - 4569

Gianluca Ianiro, Giovanni Bruno, Loris Lopetuso, Francesca Bartoli Beghella, Lucrezia Laterza, Francesca D'Aversa, Giovanni Gigante, Giovanni Cammarota and Antonio Gasbarrini


DOI: 10.2174/13816128113196660723




ATP Synthesis Revisited: New Avenues for the Management of Mitochondrial Diseases

, 20(28): 4570 - 4579

Georgios Bagkos, Kostas Koufopoulos and Christina Piperi


DOI: 10.2174/1381612819666131230124334




Impact of MCP -1 in Atherosclerosis

, 20(28): 4580 - 4588

Juntang Lin, Vijay Kakkar and Xinjie Lu


DOI: 10.2174/1381612820666140522115801




Myocardial Revascularization Strategies in Diabetic Patients with Multi-Vessel Disease: CABG vs DES-Based PCI

, 20(28): 4589 - 4596

George Kassimis, Niket Patel and Adrian P. Banning


DOI: 10.2174/1381612820666140225094157




Pleiotropic Effects of Platelet P2Y12 Receptor Inhibitors: Fact or Fiction?

, 20(28): 4597 - 4604

Athanasios Moulias, Ioanna Xanthopoulou and Dimitrios Alexopoulos


DOI: 10.2174/1381612820666140414211543




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science